Evidence map›Paper›PMID 22615553›Full record

ArticlePLoS computational biology2012

Reconstruction of genome-scale active metabolic networks for 69 human cell types and 16 cancer types using INIT.

Rasmus Agren, Sergio Bordel, Adil Mardinoglu, Natapol Pornputtapong, Intawat Nookaew, Jens Nielsen

Abstract read
In one paragraph

Article in PLoS computational biology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 235 papers.

0numbers the graph read from it
0cells of the map it votes in
235citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

235 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Dynamic metabolic modelling of ATP allocation during viral infection.Journal of the Royal Society, Interface · 2026
    Article
  5. Review
  6. Article
  7. Article
  8. Computational and structural biotechnology journal · 2026
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Longitudinal big biological data in the AI era.Molecular systems biology · 2025
    Review
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Genome-scale models in human metabologenomics.Nature reviews. Genetics · 2025
    Review

175 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Rasmus AgrenDepartment of Chemical and Biological Engineering, Chalmers University of Technology, Gothenburg, Sweden.
Sergio Bordel
Adil Mardinoglu
Natapol Pornputtapong
Intawat Nookaew
Jens Nielsen

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Development of high throughput analytical methods has given physicians the potential access to extensive and patient-specific data sets, such as gene sequences, gene expression profiles or metabolite footprints. This opens for a new approach in health care, which is both personalized and based on system-level analysis. Genome-scale metabolic networks provide a mechanistic description of the relationships between different genes, which is valuable for the analysis and interpretation of large experimental data-sets. Here we describe the generation of genome-scale active metabolic networks for 69 different cell types and 16 cancer types using the INIT (Integrative Network Inference for Tissues) algorithm. The INIT algorithm uses cell type specific information about protein abundances contained in the Human Proteome Atlas as the main source of evidence. The generated models constitute the first step towards establishing a Human Metabolic Atlas, which will be a comprehensive description (accessible online) of the metabolism of different human cell types, and will allow for tissue-level and organism-level simulations in order to achieve a better understanding of complex diseases. A comparative analysis between the active metabolic networks of cancer types and healthy cell types allowed for identification of cancer-specific metabolic features that constitute generic potential drug targets for cancer treatment.

Indexed as

AlgorithmsMetabolomeModels, BiologicalSignal TransductionAnimalsChromosome MappingComputer SimulationDatabases, ProteinHumansNeoplasmsProteomeProteome

Identifiers

PMID22615553
PMCPMC3355067

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.